Covered recipient · General Payments record
MELISSA CARO
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$1,951.26
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $408.46 | 13 |
| Travel and Lodging | $167.56 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $248.12 | 8 |
| BIOTRONIK NRO, Inc. | $132.78 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $58.43 | 1 |
| ABBVIE INC. | $52.48 | 2 |
| Lundbeck LLC | $30.29 | 1 |
| SPR Therapeutics, Inc | $18.81 | 1 |
| Collegium Pharmaceutical, Inc. | $18.13 | 1 |
| IBSA Pharma Inc. | $16.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.47 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106881085 | CMS |
| ABBVIE INC. | $20.01 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106881087 | CMS |
| BIOTRONIK NRO, Inc. | $132.78 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153859891 | CMS |
| Boston Scientific Corporation | $58.43 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092637257 | CMS |
| Collegium Pharmaceutical, Inc. | $18.13 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135334684 | CMS |
| IBSA Pharma Inc. | $16.98 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142986046 | CMS |
| Lundbeck LLC | $30.29 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146002882 | CMS |
| Nevro Corp. | $14.75 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130730797 | CMS |
| Nevro Corp. | $8.30 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130730663 | CMS |
| Nevro Corp. | $30.60 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130730767 | CMS |
| Nevro Corp. | $83.38 | 08/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1130730703 | CMS |
| Nevro Corp. | $12.94 | 08/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1130730701 | CMS |
| Nevro Corp. | $71.24 | 08/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1130730699 | CMS |
| Nevro Corp. | $7.92 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130730801 | CMS |
| Nevro Corp. | $18.99 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130730799 | CMS |
| SPR Therapeutics, Inc | $18.81 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104930539 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.